Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct-acting antivirals.

Ranya SelimYueren ZhouStuart C GordonTalan ZhangMei LuYihe G DaidaJoseph A BoscarinoMark A SchmidtSheri TrudeauLoralee B RuppHumberto C Gonzalez

Published in: Journal of viral hepatitis (2023)

After adjustment for treatment selection bias, we did not observe a significant association between HCV patients' antiviral treatment status/outcome on risk of PD/PKM. Several clinical risk factors-diabetes, cirrhosis, and BMI-were associated with PD/PKM.

Keyphrases

risk factors
type diabetes
end stage renal disease
cardiovascular disease
body mass index
chronic kidney disease
ejection fraction
hepatitis c virus
newly diagnosed
human immunodeficiency virus
parkinson disease
adipose tissue
patient reported outcomes
deep brain stimulation
patient reported